Background and objectives Various devices are used to study the unique electrical properties of acupuncture points (APs), ...

Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral ...

Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The company in March said its ALS drug Relyvrio had failed a late-stage clinical trial, and the stock has sunk more than 78% over the past year. Amylyx pulled Relyvrio from the market, cut its ...

Strattera is a prescription drug used to treat ADHD. Learn more about timing for taking the medication and more.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

UBC Okanagan researchers create an Index of Cannabis Equivalence (ICE) to standardize dosing across different consumption methods.

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than ...

Arcturus Therapeutics Holdings, Inc. engages in the development of RNA therapeutics for treatment. It focuses on liver and respiratory diseases. Its pipeline include LUNAR-OTC, and LUNAR CF. The ...